BDX
37
-3
PDCO
38
-2
BAC
44
-6
EQR
42
-8
CSCO
53
-5
KMB
31
-2
TROW
37
-5
AIZ
49
-8
IFF
51
-2
CHD
48
-2
GD
45
-5
SYY
41
2
DGX
43
-3
FIS
48
-5
PRU
54
-8
FAST
60
-3
PH
64
5
EXC
37
-3
RRC
39
-11
PSA
46
-5
BDX
37
-3
PDCO
38
-2
BAC
44
-6
EQR
42
-8
CSCO
53
-5
KMB
31
-2
TROW
37
-5
AIZ
49
-8
IFF
51
-2
CHD
48
-2
GD
45
-5
SYY
41
2
DGX
43
-3
FIS
48
-5
PRU
54
-8
FAST
60
-3
PH
64
5
EXC
37
-3
RRC
39
-11
PSA
46
-5
Financhill
Back

ACADIA Pharmaceuticals Quote, Financials, Valuation and Earnings

AI DIVIDENDS: No. 1 Way to Collect Passive Income

Click here to get it for free.
Sell
38

ACAD
ACADIA Pharmaceuticals

Last Price:
14.65
Seasonality Move:
14.68%

7 Day Trial

ALL ACCESS PASS

$ 7

You could lock in a huge 22% yield from this Energy ETF

Click HERE to check it out.

ACADIA Pharmaceuticals Price Quote

$14.65
+0.08 (+0.55%)
(Updated: November 1, 2024 at 2:25 PM ET)

ACADIA Pharmaceuticals Key Stats

Sell
38
ACADIA Pharmaceuticals (ACAD) is a Sell
Day range:
$14.45 - $14.77
52-week range:
$14.15 - $32.59
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.71
P/B ratio:
4.68%
Volume:
824.2K
Avg. volume:
1.3M
1-year change:
-35.45%
Market cap:
$2.4B
Revenue:
$726.4M
EPS:
$0.18

How Much Does ACADIA Pharmaceuticals Make?

Is ACADIA Pharmaceuticals Growing As A Company?

ACADIA Pharmaceuticals Stock Price Performance

What Is ACADIA Pharmaceuticals 52-Week High & Low?

ACADIA Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy ACADIA Pharmaceuticals?

Is ACADIA Pharmaceuticals Cash Flow Positive?

  • What Is ACAD Cash Flow From Operations?
    Cash flow from operations (TTM) is $80.5M
  • What Is ACADIA Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $22.8M
  • What Is ACADIA Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$36.5M

ACADIA Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ACAD return on invested capital is 7.04%
  • What Is ACADIA Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 4.03%
  • What Is ACAD Return On Equity?
    ROE is a measure of profitability and is 7.04%

ACADIA Pharmaceuticals Earnings Date & Stock Price

ACADIA Pharmaceuticals Competitors

ACADIA Pharmaceuticals Dividend Yield

ACADIA Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 1900% 13.9%
Revenue: 46.44% 2.67%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 25.11
Upside from Last Price: 72.31%

Major Shareholders

  • How many ACAD shares are owned by institutional investors?
    231.7M ACAD shares are owned by institutional investors
  • How many ACAD shares are owned by insiders?
    1.1M ACAD shares are owned by insiders